Historical shareholding details of SEI Tax-Managed Small/Mid Cap (SIMT) Fd holdings in Akero Therapeutics Inc (AKRO)

Monthly changes of SEI Tax-Managed Small/Mid Cap (SIMT) Fd shareholding in Akero Therapeutics Inc over the previous months

Month Name Total no. shares held Percent Holding
Jul 31, 2025 Sei Tax-Managed Small/Mid Cap (Simt) Fd 449 0.00%
Jun 30, 2025 Sei Tax-Managed Small/Mid Cap (Simt) Fd 449 0.00%
May 31, 2025 Sei Tax-Managed Small/Mid Cap (Simt) Fd 449 0.00%
Apr 30, 2025 Sei Tax-Managed Small/Mid Cap (Simt) Fd 7,476 0.01%
Mar 31, 2025 Sei Tax-Managed Small/Mid Cap (Simt) Fd 7,476 0.01%
Feb 28, 2025 Sei Tax-Managed Small/Mid Cap (Simt) Fd 10,349 0.01%
Jan 31, 2025 Sei Tax-Managed Small/Mid Cap (Simt) Fd 10,349 0.01%
Dec 31, 2024 Sei Tax-Managed Small/Mid Cap (Simt) Fd 10,349 0.01%
Nov 30, 2024 Sei Tax-Managed Small/Mid Cap (Simt) Fd 10,349 0.01%
Oct 31, 2024 Sei Tax-Managed Small/Mid Cap (Simt) Fd 10,349 0.01%
Aug 31, 2024 Sei Tax-Managed Small/Mid Cap (Simt) Fd 10,349 0.01%
Jul 31, 2024 Sei Tax-Managed Small/Mid Cap (Simt) Fd 10,349 0.01%
Jun 30, 2024 Sei Tax-Managed Small/Mid Cap (Simt) Fd 10,349 0.01%
May 31, 2024 Sei Tax-Managed Small/Mid Cap (Simt) Fd 10,349 0.01%
Apr 30, 2024 Sei Tax-Managed Small/Mid Cap (Simt) Fd 15,000 0.02%
Mar 31, 2024 Sei Tax-Managed Small/Mid Cap (Simt) Fd 15,000 0.02%
Feb 29, 2024 Sei Tax-Managed Small/Mid Cap (Simt) Fd 15,000 0.02%
Jan 31, 2024 Sei Tax-Managed Small/Mid Cap (Simt) Fd 15,000 0.03%
Dec 31, 2023 Sei Tax-Managed Small/Mid Cap (Simt) Fd 15,000 0.03%
Nov 30, 2023 Sei Tax-Managed Small/Mid Cap (Simt) Fd 15,000 0.03%
Oct 31, 2023 Sei Tax-Managed Small/Mid Cap (Simt) Fd 30,983 0.06%
Sep 30, 2023 Sei Tax-Managed Small/Mid Cap (Simt) Fd 30,983 0.06%
Aug 31, 2023 Sei Tax-Managed Small/Mid Cap (Simt) Fd 30,983 0.06%
Jul 31, 2023 Sei Tax-Managed Small/Mid Cap (Simt) Fd 30,983 0.06%
Jun 30, 2023 Sei Tax-Managed Small/Mid Cap (Simt) Fd 30,983 0.06%
May 31, 2023 Sei Tax-Managed Small/Mid Cap (Simt) Fd 30,983 0.06%
Apr 30, 2023 Sei Tax-Managed Small/Mid Cap (Simt) Fd 30,983 0.06%

View all ownership details of Akero Therapeutics Inc